UK-wide COVID vaccination coverage study reveals gaps and preventable hospitalizations

Between a third and a half of the populations of the four UK nations had not had the recommended number of COVID vaccinations and boosters by summer 2022, according to the first research study to look at COVID-19 vaccine coverage of the entire UK population.

Biogen ends agreement with Acorda for multiple sclerosis drug Fampyra

Biogen is handing back ex-US commercialization rights to Acorda Therapeutics for the multiple sclerosis drug Fampyra. Acorda will have the drug in-house effective Jan. 1,

January 12, 2024

Celmatix and Aché Laboratórios partner to tackle unmet need for PCOS drugs – Pharmaceutical Technology

PCOS can cause several symptoms including painful menstrual cramps. Getty Images/ Witthaya Prasongsin Celmatix and Aché Laboratórios have announced a partnership and license option agreement

August 9, 2023

Regional Approach Effective in Reducing Multi-Drug Resistant Bacteria

A county-wide decolonization intervention in nursing homes and among selected hospital patients led to fewer multidrug-resistant organism (MDRO) infections, hospitalizations, and deaths across the region,

April 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.